Testing effectiveness (Phase 2)Ended earlyNCT00027508What this trial is testingEcteinascidin 743 in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma PharmaMar
Not applicableStudy completedNCT03068117What this trial is testingMalignant Mesothelioma - Can we Improve Quality of LifeWho this might be right forMesothelioma, Malignant Portsmouth Hospitals NHS Trust 319
Not applicableEnded earlyNCT06315296What this trial is testingAn Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Carcinoma+2 more Thomas Jefferson University 1
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Testing effectiveness (Phase 2)Study completedNCT00017186What this trial is testingGemcitabine and Epirubicin in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 69
Not applicableStudy completedNCT01178190What this trial is testingThe Role of Narrow Band Imaging Videobronchoscopy in Lung CancerWho this might be right forLung Cancer Asan Medical Center 101
Not applicableEnded earlyNCT01052766What this trial is testingBreathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor GlycolysisWho this might be right forLung CancerNon-small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Study completedNCT00821860What this trial is testingVideo-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant MesotheliomaMetastatic Cancer Papworth Hospital NHS Foundation Trust 196
Testing effectiveness (Phase 2)Study completedNCT02038218What this trial is testingStudy of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain TumorsWho this might be right forPrimary Brain TumorsMetastatic Malignant Neoplasm to Brain DEKK-TEC, Inc. 29
Testing effectiveness (Phase 2)WithdrawnNCT06654050What this trial is testingAlrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage MesotheliomaWho this might be right forMesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00458913What this trial is testingBortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Early research (Phase 1)Ended earlyNCT05578092What this trial is testingMRTX0902 in Solid Tumors With Mutations in the KRAS MAPK PathwayWho this might be right forSolid TumorAdvanced Solid TumorNon Small Cell Lung Cancer+1 more Mirati Therapeutics Inc. 64
Early research (Phase 1)Ended earlyNCT05229900What this trial is testingSGN-ALPV in Advanced Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung+4 more Seagen Inc. 43
Not applicableActive Not RecruitingNCT07638228What this trial is testingEvaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary NodulesWho this might be right forMalignant Pulmonary NodulesLung Cancer Sir Run Run Shaw Hospital 5
Testing effectiveness (Phase 2)UnknownNCT01279967What this trial is testingA Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Barts & The London NHS Trust 70
Very early researchUnknownNCT05565014What this trial is testingSafety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal EffusionWho this might be right forMalignant Pleural EffusionMalignant Peritoneal Effusion Sheng Hu 90